Table 3 Results of colocalisation analyses for RHOD and CDC42 genes.
From: Rho GTPase gene expression and breast cancer risk: a Mendelian randomization analysis
Overall breast cancer | ER+ breast cancer | ER− breast cancer | |
---|---|---|---|
RHOD (GTEx) | |||
PP Hypothesis0 | 4.68 × 10–10 | 2.29 × 10–11 | 9.26 × 10–9 |
PP Hypothesis1 | 0.04 | 0.002 | 0.85 |
PP Hypothesis2 | 9.63 × 10–10 | 1.98 × 10–10 | 6.77 × 10–10 |
PP Hypothesis3 | 0.09 | 0.02 | 0.06 |
PP Hypothesis4 | 0.87 | 0.98 | 0.09 |
CDC42 (eQTLGen) | |||
PP Hypothesis0 | 9.36 × 10–306 | 1.78 × 10–305 | 2.54 × 10–305 |
PP Hypothesis1 | 0.33 | 0.62 | 0.89 |
PP Hypothesis2 | 3.42 × 10–306 | 3.15 × 10–306 | 3.05 × 10–306 |
PP Hypothesis3 | 0.12 | 0.11 | 0.11 |
PP Hypothesis4 | 0.55 | 0.27 | 0.007 |